John Wayne Cancer Institute

See schedule oprovidence st. joseph health systemon july 1, 2016, providence health & services (phs) and st. joseph health system (sjhs) entered into a business combination agreement. By coming together, providence st. joseph health seeks to better serve its communities through greater patient affordability, outstanding clinical care, improvements to the patient experience and introduction of new services where they are needed most. Together, our caregivers serve in 51 hospitals, 829 clinics across Alaska, California, Montana, new mexico, Oregon, Texas and washington.the founders of both organizations were courageous women ahead of their time. The sisters of providence and the sisters of st. joseph of orange brought health care and other social services to the american west when it was still a rugged, untamed frontier. Now, as we face a different landscape - a changing health care environment - we draw upon their pioneering and compassionate spirit to plan for the next ...

See schedule otranslational immunology: the department of translational neuro-oncology and neurotherapeutics (tnon) was established at jwci in august 2015. Tnon's research areas include discovery and development of novel drug candidates for clinically validated molecular targets, biomarker-based drug development for precision medicine, nanotechnology-based approaches to deliver drugs across the blood brain barrier, new immunological approaches to diagnose and treat Cancer and cns diseases, and integrated information technology, big data and novel biosensor/device development. This is accomplished through basic science research, preclinical research, translational research, and clinical research.tnon's basic science research explores specific aspects of how brain Cancer initiates and progresses. Active initiatives include tumor cell metabolism, molecular signaling pathways and nanotechnology in drug delivery. Tnon's preclinical research evaluates discoveries from basic research in preclinical animal models. Patient derived xenograft (pdx) and orthotopic animal models are employed for testing of novel therapeutic agents targeting brain tumors. A major focus is evaluating targeted ...

See schedule omelanoma research: jwci has one the largest melanoma programs in the world. Research has involved international multicenter clinical trials, industry sponsored clinical trials, and basic science research. Results of these studies have been published in numerous peer-review journals including the new england journal of medicine. There are ongoing potentially practice-changing clinical trials in melanoma. Basic science research includes genomics, translational immunology and the development of novel immunotherapies.